Form D — Kamal Therapeutics, Inc.
0001880064-25-000004 · filed 2025-11-24
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $17,307,138
- Total sold
- $13,807,138
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Kamal Therapeutics, Inc.
- CIK
- 1880064
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 66 CLUBHOUSE DRIVE
HINGHAM, MA 02043 - Phone
- 857 222 4653
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Mark de Souza · Executive OfficerHingham, MA Find on LinkedIn ↗
-
Philip Reilly · DirectorHingham, MA Find on LinkedIn ↗
-
John Parker · DirectorHingham, MA Find on LinkedIn ↗
View original on SEC EDGAR.